Beijing Minhai Biotechnology Co.,Ltd

[Specification] 0.5 ml per bottle. Each dose for human use is 0.5 ml, containing purified type b capsular Polysaccharide of Haemophilus Influenzae  shall not less than 10μg.

[Vaccination subjects]For children aged from 3 months to 5 years.

[Function and use]The vaccination can stimulate the body to produce humoral immune response.  This product is used for preventing diseases caused by Haemophilus Influenzae Type b(including Meningitis, pneumonia, septicemia, cellulitis, arthritis, epiglottitis,etc)

[Shelf life] 24 months

[Highlights]

•The strain used for Hib Vaccine production was independently seperated by  Minhai Company.                                      •Carrier  Protein is Tetanus toxoid which was widely used in globe.

• Low rate of adverse reactions in location.                                                                                                      •Does not contain gelatin, thimerosal, aluminum hydroxide, reduce the incidence of abnormal reaction